Boosting oncolytic virus-mediated antitumor immunity by dendritic cell vaccine therapy via p53-activated immune response [abstract]. In: Proceedings of the American Association for Cancer Research ...

Despite the advancements in targeted biologic therapy for immune-mediated inflammatory diseases (IMIDs), significant challenges persist, including challenges in drug maintenance, primary and secondary ...

Innate immune cell-mediated anti-tumor activity against lung cancer and pleural mesothelioma cells [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2025; Part ...

Discover a study where researchers have discovered a myeloid-derived antigen-presenting cells population essential for peripherally induced regulatory T cells.

PharmaJet to present partner data showing how needle-free can be expected to enhance vaccine immune response in ...

The tumor microenvironment is a harsh environment where metabolic adaptations are key. In this article, we explore how the ...

The following is a summary of "ADORA2B promotes proliferation and migration in head and neck squamous cell carcinoma and is ...

Research has shed light on how a new type of antibody treatment reactivates patients' immune cells to fight ovarian cancer.

Rodents fed a diet high in soluble fiber showed improved resistance to a microorganism that causes diarrhea and can be fatal ...